Skip to content
healthcare.dev
Get a free key

Aplenzin

NDC 0187-5811, bupropion hydrobromide, tablet, extended release, from Bausch Health US, LLC.

Product NDC
0187-5811
Status
Listed
Labeler
Bausch Health US, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022108
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0187-5811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROBROMIDE348 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
0187-5811-07001875811077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)
0187-5811-300018758113030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6494d2d9-0ce4-4126-b1c7-49684395942b

Use it

Look up 0187-5811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0187-5811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0187-5811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.